IsoPlexis to Participate in the Morgan Stanley Global Healthcare Conference

Rhea-AI Summary

IsoPlexis Corporation (Nasdaq: ISO) announced participation in the Morgan Stanley Global Healthcare Conference on September 12, 2022. The management will engage in a fireside chat at 4:50 p.m. ET, which will also be available as a live and archived webcast on the company’s website. IsoPlexis aims to empower labs by enhancing the understanding of multi-functional immune cells, aiding in the prediction of disease progression and treatment responses. Recognized for its innovative platform, IsoPlexis serves top pharmaceutical firms and leading cancer centers globally.

BRANFORD, Conn., Aug. 31, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO) (“IsoPlexis”), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced it will be participating in the upcoming Morgan Stanley Global Healthcare Conference in New York, NY.

IsoPlexis’ management is scheduled to participate in a fireside chat on Monday, September 12th at 4:50 p.m. Eastern Time / 1:50 p.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.isoplexis.com.

About IsoPlexis

IsoPlexis is empowering labs, changing the course of human health.

By leading the discovery and identification of how multi-functional immune cells communicate and respond, IsoPlexis assists researchers in understanding and predicting disease progression, treatment resistance and therapeutic efficacy.

IsoPlexis has been named Top Innovation or Design by The Scientist Magazine, Fierce, BIG Innovation, Red Dot and multiple others. The IsoPlexis platform is used globally by researchers, including those at the top 15 global pharmaceutical companies by revenue and 78% of leading U.S. comprehensive cancer centers.

Investor Contact
investors@isoplexis.com

Press Contact
press@isoplexis.com

FAQ

When is IsoPlexis participating in the Morgan Stanley Global Healthcare Conference?

IsoPlexis will participate in the Morgan Stanley Global Healthcare Conference on September 12, 2022.

What time will the IsoPlexis management's fireside chat take place?

The fireside chat will take place at 4:50 p.m. Eastern Time on September 12, 2022.

How can I access the IsoPlexis conference presentation?

The presentation can be accessed live and archived on IsoPlexis’ website in the 'Investors' section.

What is the focus of IsoPlexis's research and technology?

IsoPlexis focuses on understanding multi-functional immune cells to improve predictions of disease progression and treatment efficacy.

Which notable organizations use IsoPlexis's platform?

IsoPlexis's platform is utilized by top global pharmaceutical companies and 78% of leading U.S. comprehensive cancer centers.